Roper Technologies (ROP) Q2 2024 earnings summary

Executive summary

• Q2 2024 revenue grew 12% year-over-year to $1.72 billion, with 4% organic growth and 13% adjusted EBITDA growth to $695 million; free cash flow rose 24% to $367 million, with TTM free cash flow margin at 32%.

• Adjusted DEPS increased 9% to $4.48, while GAAP DEPS fell 7% to $3.12; net earnings from continuing operations were $337.1 million, impacted by higher interest expense and lower equity investment gains.

• Raised the bottom end of full-year adjusted EPS/DEPS guidance, citing strong demand for mission-critical solutions and recurring revenue expansion.

• Maintains robust M&A capacity of over $4 billion and a strong pipeline of acquisition opportunities, including the completed $1.86 billion Procare acquisition.

• Operating cash flow for the first six months rose 17% year-over-year to $915.6 million, driven by higher net earnings and improved collections.

Financial highlights

• Q2 2024 revenue was $1.72 billion (+12% year-over-year), with 4% organic growth and 8% from acquisitions.

• Adjusted EBITDA grew 13% to $695 million, with a margin of 40.5%, up 20 bps year-over-year.

• Adjusted DEPS was $4.48, exceeding guidance; GAAP DEPS was $3.12.

• Free cash flow was $367 million in Q2, up 24% year-over-year; TTM free cash flow was $2.1 billion, with a 32% margin.

• Gross margin for Q2 2024 was 69.5%; operating margin was 28.8% (up from 28.4% in Q2 2023).

Outlook and guidance

• Maintained full-year 2024 outlook for 12% total revenue growth and 6% organic revenue growth.

• Raised full-year adjusted EPS/DEPS guidance to $18.10–$18.25; Q3 adjusted EPS/DEPS expected between $4.50 and $4.54.

• Free cash flow margins expected to normalize at 30% or more for 2024.

• Guidance excludes impacts from unannounced acquisitions or divestitures.

• Management anticipates continued positive operating cash flows and plans to reduce debt in line with the repayment schedule.